Pedro Almela Notari
- Helicobacter pylori-related gastroenterology studies
- Gastrointestinal disorders and treatments
- Microscopic Colitis
- Gastrointestinal Bleeding Diagnosis and Treatment
- Gastroesophageal reflux and treatments
- Psychiatric care and mental health services
- Esophageal and GI Pathology
- Gastrointestinal motility and disorders
- Cerebrovascular and Carotid Artery Diseases
- Autoimmune and Inflammatory Disorders
- Congenital Diaphragmatic Hernia Studies
- Pelvic floor disorders treatments
- Health, Medicine and Society
- Veterinary medicine and infectious diseases
- Management, Economics, and Public Policy
- Eosinophilic Esophagitis
- Gastric Cancer Management and Outcomes
- Voice and Speech Disorders
- Congenital gastrointestinal and neural anomalies
- Tracheal and airway disorders
- Dysphagia Assessment and Management
- Myofascial pain diagnosis and treatment
- Gastrointestinal Tumor Research and Treatment
- Educational and Social Studies
- Adrenal Hormones and Disorders
Hospital General Universitari de Castelló
2017-2024
Hospital Clínico Universitario de Valencia
2004-2012
Universitat de València
2004-2008
Ospedale Sandro Pertini
2000
The recommended schedule for single capsule bismuth quadruple therapy (scBQT, Pylera) includes a proton pump inhibitor (PPI) two times day and three scBQT capsules four day. Four treatments are inconvenient reduce adherence. In contrast, adherence improves with schedules. clinical practice, many gastroenterologists use However, the effectiveness safety of this latter approach remain uncertain.To assess administered in patients included European Registry on Helicobacter pylori Management...
Crohn's disease (CD) varies by location, potentially affecting therapy efficacy and surgery risk, although research on this topic is conflicting. This study aims to investigate the independent association between CD location therapeutic patterns.